|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of PhaseBio Pharmaceuticals (NASDAQ: PHAS) through any online brokerage.
The latest price target for PhaseBio Pharmaceuticals (NASDAQ: PHAS) was reported by Needham on March 16, 2021. The analyst firm set a price target for 19.00 expecting PHAS to rise to within 12 months (a possible 413.51% upside). 1 analyst firms have reported ratings in the last year.
The stock price for PhaseBio Pharmaceuticals (NASDAQ: PHAS) is $3.7 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for PhaseBio Pharmaceuticals.
There is no upcoming split for PhaseBio Pharmaceuticals.
PhaseBio Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.